National Institute for Bioprocessing Research and Training (NIBRT) Research Summary: In 2011, funding was initially received from the PCC to evaluate Structural differences as a biomarker of EPO use, and this enabled N-glycan profiling of 15 biosimilar recombinant erythropoietins using a 2-AB label
SattarNRawshaniAFranznSRawshaniASvenssonAMRosengrenAet al
The oral-contraceptive interaction is a separate study (GPGR), reported in the FDA Mounjaro NDA 215866 summary review: a single 5 mg tirzepatide dose with a combination oral contraceptive (0.035 mg ethinyl estradiol / 0.25 mg norgestimate) reduced the Cmax of norelgestromin and ethinyl estradiol by 55% to 59% a range spanning both analytes, not a separate figure for each with AUC lowered 28.8% (norelgestromin) and 27% (ethinyl estradiol), and tmax delayed 2.5 to 4.5 hours
Vitamin K2 (MK-4) Research 35 Koitaya N, Sekiguchi M, Tousen Y, Nishide Y, Morita A, Yamauchi J, Gando Y, Miyachi M, Aoki M, Komatsu M, Watanabe F, Morishita K, Ishimi Y
Clinical basis: NICE vitamin B12 deficiency recommendations, NHS vitamin B12 deficiency treatment guidance and NHS hydroxocobalamin information